Connection

PETER JINDRA to HLA Antigens

This is a "connection" page, showing publications PETER JINDRA has written about HLA Antigens.
Connection Strength

2.777
  1. Potential synergistic role of pre-formed GSTT1 antibodies and de novo HLA antibodies in a heart-transplant recipient diagnosed with AMR. Hum Immunol. 2026 Feb; 87(2):111648.
    View in: PubMed
    Score: 0.843
  2. Human Leukocyte Antigen Epitope Matching in Solid Organ Transplantation. Clin Lab Med. 2018 12; 38(4):595-605.
    View in: PubMed
    Score: 0.509
  3. HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol. 2008 Feb 15; 180(4):2357-66.
    View in: PubMed
    Score: 0.244
  4. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation. 2006 Jul 15; 82(1 Suppl):S33-5.
    View in: PubMed
    Score: 0.218
  5. Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative. Am J Transplant. 2025 Oct; 25(10):2048-2056.
    View in: PubMed
    Score: 0.203
  6. Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions. Hum Immunol. 2022 May; 83(5):467-475.
    View in: PubMed
    Score: 0.161
  7. Minimal data reporting standards for serological testing for histocompatibility. Hum Immunol. 2018 Dec; 79(12):865-868.
    View in: PubMed
    Score: 0.126
  8. Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2017 11 06; 7(1):14554.
    View in: PubMed
    Score: 0.120
  9. Analysis of a Genetic Polymorphism in the Costimulatory?Molecule TNFSF4 with Hematopoietic Stem?Cell?Transplant Outcomes. Biol Blood Marrow Transplant. 2016 Jan; 22(1):27-36.
    View in: PubMed
    Score: 0.103
  10. Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
    View in: PubMed
    Score: 0.092
  11. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol. 2004 Apr; 65(4):291-302.
    View in: PubMed
    Score: 0.047
  12. Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders. Front Immunol. 2022; 13:900605.
    View in: PubMed
    Score: 0.042
  13. Optimal Donor Selection During Verification Process: Which Factors Are Worth Knowing? Transplant Proc. 2018 Dec; 50(10):3082-3087.
    View in: PubMed
    Score: 0.032
  14. A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant. 2014 Mar; 49(3):376-81.
    View in: PubMed
    Score: 0.023
  15. Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2009 Aug; 44(4):227-35.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.